Clinical Trial Update: Sleep Quality in CHIMES (MF101) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Bionovo evaluating MF101 (CHIMES) for sleep quality in menopausal symptoms; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• MF101 (CHIMES)

Snippet

Sponsor: Bionovo | Conditions: Sleep Quality, Menopausal Symptoms | Phase 2 | Status: COMPLETED